
BIO Boston: 2025 is shaping up to be a year of challenge – b...
What were the major themes to come out of BIO Boston 2025? Despite global events in the background, a fair amount of positivity.
Newsletters and Deep Dive digital magazine
What were the major themes to come out of BIO Boston 2025? Despite global events in the background, a fair amount of positivity.
Real-world evidence (RWE) has moved from the periphery to the centre of how healthcare decisions are made.
Claus Zieler, chief commercial and medical affairs officer & member of the Executive Committee at Astellas Pharma, spoke with pharmaphorum at ASCO25.
The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and biotechnology sectors.
ASCO 2025 may be over, but the insights for the future of oncology are only just beginning.
Editor's Picks
Newsletters and Deep Dive
digital magazine